Atlas Trials

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)

Clinical trial NCT01863693 · COMPLETED

Trial details

NCT number
NCT01863693
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Ovarian Cancer
Start date
2013-05-10
Primary completion
2018-06-15
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.